Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence
NCT ID: NCT03390400
Last Updated: 2018-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2017-05-29
2018-03-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cataract surgery will be performed in subjects who have signed an informed consent form. Aqueous humor will be collected and screening will be performed for Total Prostaglandin and Prostaglandin E2 via en-bloc Enzyme-linked Immunosorbent Assay (ELISA)-Kit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Release of Proinflammatory Cytokines (IL-1β, IL-6) and Total-prostaglandin (PG) Following Femtosecond Laser-assisted Cataract Surgery Compared to Manual Cataract Surgery
NCT03390361
A Prospective Single Center Clinical Study for Capsulotomy Using the LenSx 550 Laser
NCT00959322
A Study of Cataract Surgery With the Femtosecond Laser
NCT00922571
Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery
NCT04747834
Femtosecond Laser for Cataract Surgery
NCT02110212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anterior Capsulotomy before Lens Fragmentation
Anterior capsulotomy will be performed by femtosecond laser before lens fragmentation
Femtosecondlaser-assisted
Femtosecondlaser-assisted Cataract Surgery will be performed bilateral on the same day with different laser settings.
Anterior Capsulotomy
Cataract Surgery
Lens Fragmentation before Anterior Capsulotomy
Lens fragmentation will be performed by femtosecond laser before anterior capsulotomy
Femtosecondlaser-assisted
Femtosecondlaser-assisted Cataract Surgery will be performed bilateral on the same day with different laser settings.
Lens Fragmentation
Cataract Surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femtosecondlaser-assisted
Femtosecondlaser-assisted Cataract Surgery will be performed bilateral on the same day with different laser settings.
Anterior Capsulotomy
Cataract Surgery
Lens Fragmentation
Cataract Surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 40 to 90 (females of childbearing age will be interviewed if pregnancy is possible)
* Preoperative pupil dilation in mydriasis ≥ 6.5 mm
Exclusion Criteria
* Recurrent intraocular inflammation of unknown etiology
* Uncontrolled glaucoma
* Uncontrolled systemic or ocular disease
* Blind fellow eye
* Microphthalmus
* Corneal abnormality
* History of uveitis/iritis
* Iris neovascularization
* Pseudoexfoliation
* Proliferative diabetic retinopathy
* Pregnancy
* Lactation
* Females of childbearing age: not included
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rupert Menapace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rupert Menapace
Prof. Dr. med. univ.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rupert Menapace, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Femto-PGII Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.